| Factor | Score | Distribution | Value | Avg | Rank |
|---|---|---|---|---|---|
Valuation | 99 | 0.1x | 17.4x | Top tier | |
Growth | 26 | 13.2% | 7.1% | Bottom tier | |
Quality | 63 | — | — | Around median | |
Safety | 14 | — | — | Bottom tier | |
Capital Return | 100 | 76.79% | 0.18% | Top tier | |
Momentum | 23 | -9.3% | 1.3% | Bottom tier | |
Sentiment | 1 | 1 | 3 | Bottom tier |

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.
First Citizens BancShares operates through a diversified banking franchise encompassing General Banking, Commercial Banking, Global Fund Banking, Tech & Healthcare, and Middle Market Banking, alongside Wealth Management and Direct Bank. Revenue is generated from net interest income on loans and interest-earning assets, as well as fees from investment and wealth management, deposits, lending, cards, merchant services, international activities, factoring, and rail operations. In Q2 FY2026 ended 2026-06-30, loan growth came particularly from Global Fund Banking, Tech & Healthcare, and Middle Market Banking, while Direct Bank added $2.8 billion in deposits and offset a $1.5 billion decline in Commercial Bank deposits.
Revenue for Q2 FY2026 ended 2026-06-30 was approximately $3.6 billion, up 51.9% year over year from $2.4 billion in Q2 FY2025. Net income was $672.0 million, diluted earnings per share were $55.48, and operating cash flow was $1.0 billion. In contrast, gross margin was 67.1% versus 95.2% a year earlier, while operating margin was 24.7% versus 31.9%, meaning the revenue surge did not translate into a comparable improvement in margins.
The business mix reflects simultaneous strength in specialized lending and fees: Global Fund Banking loans increased by $2.6 billion, Tech & Healthcare loans grew 3.7% sequentially, and Middle Market Banking added approximately $205 million. Wealth management fees also increased 12% year over year, but $50 million of the growth in noninterest income came from asset monetization and portfolio revaluations, including a $27 million gain from the equity warrant portfolio and a $17 million gain from the sale of a tax credit investment; therefore, not all income growth was equally recurring.
Q2 FY2026
When: Q3 FY2026
Loans reach $152 billion, the lower end of quarterly guidance
Deposits reach $179 billion, the lower end of quarterly guidance
Net interest income reaches $1.63 billion, the lower end of quarterly guidance
No calculated values are available from the discounted cash flow model, industry multiple, zero-growth value, or numerical analyst price targets. The available valuation indicator is the analyst consensus recommendation of “Buy,” but it does not allow a quantitative comparison among independent valuation methods. The EL7 score provides relative context only, with the valuation pillar ranking 9 out of 539 within the industry and scoring 99 out of 100, without representing an independent fair value in dollars.
Figures in the text are as of 2026-09-27; the live price is shown at the top of the page.
Revenue reached $3.6 billion in Q2 FY2026 ended 2026-06-30, representing year-over-year growth of 51.9% from $2.4 billion. Period-end loans increased by $2.3 billion, led by $2.6 billion of growth in Global Fund Banking, while Tech & Healthcare increased 3.7% and Middle Market Banking added approximately $205 million. Noninterest income also benefited from core business fees, as well as $27 million in equity warrant gains and $17 million from the sale of a tax credit investment.
Management expects the transaction to close in Q3 FY2026 and add approximately $5.3 billion in deposits and $700 million in loans. This is included in quarterly guidance of $179 billion to $182 billion for deposits and $152 billion to $155 billion for loans. The company also expects to use the liquidity generated by the transaction as part of a $6 billion to $8 billion repayment of the purchase money note owed to FDIC during the same quarter.
Automated analysis for informational purposes only — not investment advice.
Net charge-offs remain at 40 basis points, the upper end of quarterly guidance
The net charge-off rate was 29 basis points in Q2 FY2026 ended 2026-06-30, following a sequential improvement of one basis point. Nonaccrual loans remained unchanged at 96 basis points of total loans, and management expects them to decline during the second half of FY2026. However, the company still expects charge-offs in commercial office real estate and innovation portfolios to continue and guided to a range of 30 to 40 basis points for Q3 FY2026.
Management set Q3 FY2026 net interest income guidance at $1.63 billion to $1.71 billion, expecting it to remain approximately stable compared with the previous quarter. The main pressure is intense competition for deposits; Direct Bank's spot rate was 3.71% and its highest offered rate was 4.1%. Management expects deposits to reprice faster than variable-rate loans, so most of the benefit from any increase in interest rates would appear during FY2027 rather than late FY2026.
Through 2026-07-21, the company repurchased more than 20% of its outstanding common shares for a total of $6.3 billion, equivalent to approximately 84% of the available authorization. Repurchase spending was $600 million in Q2 FY2026, and management expects approximately $600 million in Q3 and $300 million in Q4. At the same time, the CET1 ratio was approximately 10.77% at the end of Q2, and management is targeting a range of 10% to 10.5% while moderating the pace of repurchases.
Gross margin was 67.1% in Q2 FY2026 ended 2026-06-30, versus 95.2% in the corresponding period of FY2025, a decrease of 28.0 percentage points. Operating margin also declined to 24.7% from 31.9%, a decrease of 7.2 percentage points, despite revenue growth of 51.9%. This places the quality of revenue growth and the efficiency of its conversion into operating profit among the most important items that the 2026-10-22 report should clarify.